Shibo Jiang Selected Research

Viral Fusion Proteins

1/2022

The Analogs of Furanyl Methylidene Rhodanine Exhibit Broad-Spectrum Inhibitory and Inactivating Activities against Enveloped Viruses, including SARS-CoV-2 and Its Variants.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shibo Jiang Research Topics

Disease

160	Infections 11/2022 - 09/2002
31	Virus Diseases (Viral Diseases) 11/2022 - 03/2005
30	COVID-19 04/2022 - 01/2020
23	Human Influenza (Influenza) 07/2020 - 08/2006
21	Severe Acute Respiratory Syndrome 04/2022 - 09/2004
20	Acquired Immunodeficiency Syndrome (AIDS) 01/2022 - 01/2002
11	HIV Infections (HIV Infection) 01/2020 - 01/2002
8	Coronavirus Infections 01/2022 - 01/2015
7	Influenza in Birds (Avian Flu) 01/2015 - 07/2010
6	Zika Virus Infection 09/2021 - 01/2017
5	Neoplasms (Cancer) 04/2019 - 02/2008
4	Communicable Diseases (Infectious Diseases) 01/2022 - 01/2017
4	Lung Injury 11/2020 - 01/2014
4	Uterine Cervical Neoplasms (Cancer of the Cervix) 04/2019 - 08/2015
4	Papillomavirus Infections 01/2019 - 06/2013
3	Bites and Stings (Sting) 01/2022 - 01/2020
3	Respiratory Syncytial Virus Infections 01/2021 - 01/2013
3	Inflammation (Inflammations) 01/2020 - 06/2012
3	Acute Lung Injury 04/2018 - 10/2011
2	Immune System Diseases (Immune Disorders) 11/2020 - 01/2017
2	Emerging Communicable Diseases (Emerging Infectious Diseases) 05/2020 - 03/2016
2	Poisoning 01/2018 - 10/2011
2	Hemorrhagic Fever with Renal Syndrome (HFRS) 09/2008 - 11/2002
1	Lassa Fever (Fever, Lassa) 01/2022

Drug/Important Bio-Agent (IBA)

62	VaccinesIBA 04/2022 - 09/2004
60	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2004
45	Antiviral Agents (Antivirals)IBA 04/2022 - 09/2002
42	Peptides (Polypeptides)IBA 01/2022 - 01/2002
24	Neutralizing AntibodiesIBA 01/2022 - 09/2006
17	AntibodiesIBA 04/2022 - 11/2004
16	Pharmaceutical PreparationsIBA 11/2022 - 01/2002
16	Monoclonal AntibodiesIBA 01/2022 - 11/2002
13	Anti-Infective Agents (Microbicides)IBA 01/2017 - 04/2002
11	Subunit VaccinesIBA 01/2022 - 01/2008
10	Glycoproteins (Glycoprotein)IBA 01/2022 - 04/2002
10	EpitopesIBA 10/2019 - 11/2002
9	HIV Fusion InhibitorsIBA 01/2022 - 01/2002
8	Recombinant ProteinsIBA 01/2022 - 09/2008
8	Immunoglobulin G (IgG)IBA 01/2022 - 12/2006
8	Amyloid (Amyloid Fibrils)IBA 01/2018 - 11/2012
8	Enfuvirtide (Fuzeon)FDA Link 08/2015 - 01/2004
7	Immune Sera (Antisera)IBA 11/2020 - 09/2004
5	Human Serum Albumin FDA LinkGeneric 03/2022 - 03/2013
5	Anti-HIV Agents (AIDS Drugs)IBA 01/2022 - 01/2002
5	Hemagglutinins (Hemagglutinin)IBA 07/2020 - 06/2013
5	Reverse Transcriptase InhibitorsIBA 07/2018 - 01/2004
5	Protease Inhibitors (Protease Inhibitor)IBA 12/2012 - 01/2002
4	Peptide Hydrolases (Proteases)FDA Link 04/2022 - 09/2005
4	Broadly Neutralizing AntibodiesIBA 01/2022 - 01/2017
4	CytokinesIBA 11/2020 - 06/2012
4	Complement System Proteins (Complement)IBA 04/2018 - 10/2011
4	3-hydroxyphthalic anhydrideIBA 11/2013 - 04/2011
3	LipopeptidesIBA 04/2022 - 04/2020
3	COVID-19 VaccinesIBA 01/2022 - 01/2021
3	CholesterolIBA 01/2022 - 06/2014
3	Polysaccharides (Glycans)IBA 07/2021 - 06/2005
3	Interleukin-6 (Interleukin 6)IBA 11/2020 - 06/2012
3	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 10/2020 - 08/2002
3	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2020 - 07/2010
3	InterferonsIBA 01/2020 - 01/2014
3	Nelfinavir (Viracept)FDA Link 04/2019 - 08/2015
3	Zidovudine (Retrovir)FDA LinkGeneric 07/2018 - 05/2005
3	NucleosidesIBA 07/2018 - 12/2010
3	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 01/2017 - 01/2013
3	AntigensIBA 12/2016 - 09/2008
3	OvalbuminIBA 03/2013 - 09/2008
3	CD4 Antigens (CD4 Antigen)IBA 01/2013 - 09/2005
3	sifuvirtideIBA 02/2011 - 04/2008
2	Therapeutic UsesIBA 04/2022 - 10/2019
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2022 - 08/2005
2	GossypolIBA 01/2022 - 11/2019
2	Inactivated VaccinesIBA 01/2022 - 09/2008
2	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2022 - 01/2020
2	Drug CombinationsIBA 01/2021 - 04/2019
2	Metformin (Glucophage)FDA LinkGeneric 04/2019 - 01/2017
2	ParaquatIBA 01/2018 - 10/2011
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2018 - 01/2013
2	Peptide FragmentsIBA 01/2018 - 10/2017
2	avian influenza A virus hemagglutininIBA 10/2017 - 10/2013
2	4Dm2mIBA 06/2017 - 05/2016
2	HIV Protease InhibitorsIBA 01/2017 - 08/2015
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 06/2012
2	Biological ProductsIBA 02/2016 - 08/2005
2	ADS J1IBA 09/2015 - 05/2014
2	Palivizumab FDA Link 02/2015 - 01/2013
2	Maleic Anhydrides (Maleic Anhydride)IBA 02/2015 - 03/2013
2	Amino Acids FDA Link 06/2013 - 09/2006
2	piperidineIBA 05/2012 - 06/2011
2	Recombinant Fusion ProteinsIBA 01/2011 - 10/2010
2	Human immunodeficiency virus 1 reverse transcriptaseIBA 09/2010 - 05/2005
2	IntegrasesIBA 09/2010 - 09/2005
2	SARS-CoV spike glycoproteinIBA 01/2008 - 03/2004
2	Immunodominant EpitopesIBA 08/2005 - 09/2004
1	Phosphotransferases (Kinase)IBA 11/2022
1	Viral Fusion ProteinsIBA 01/2022
1	ManganeseIBA 01/2022

Therapy/Procedure

44	Therapeutics 01/2022 - 04/2006
6	Highly Active Antiretroviral Therapy (HAART) 01/2022 - 05/2011
3	Salvage Therapy 07/2018 - 09/2014
1	Inhalation Administration 01/2022